Megan Buresh
Overview
Explore the profile of Megan Buresh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
225
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Salisbury-Afshar E, Buresh M, Buchheit B, McCart R, Finnell D
Subst Use Addctn J
. 2025 Mar;
:29767342251320201.
PMID: 40026170
This commentary provides an overview of the 2024 Association of Multidisciplinary Education and Research in Substance Use and Addiction annual conference: Empowering Change: From Evidence to Action in Addiction Care...
2.
Gupta N, Hiebert L, Saseetharran A, Chappell C, El-Sayed M, Hamid S, et al.
Am J Obstet Gynecol
. 2024 Jul;
231(4):377-385.
PMID: 38960017
There is an increasing burden of hepatitis C virus among persons of reproductive age, including pregnant and breastfeeding women, in many regions worldwide. Routine health services during pregnancy present a...
3.
Buresh M, Buchheit B, Wason K, Northup R, Bratberg J, Finnell D
Subst Use Addctn J
. 2024 Jan;
45(2):156-162.
PMID: 38288714
This commentary provides an overview of the 2023 Association of Multidisciplinary Education and Research in Substance use and Addiction (AMERSA) annual conference: Advocacy for Equity Around Evidence-Based Treatments, held from...
4.
Bowman L, Berger O, Nesbit S, Stoller K, Buresh M, Stewart R
Am J Health Syst Pharm
. 2023 Dec;
81(6):204-218.
PMID: 38091380
Purpose: To describe one strategy for dispensing of methadone at emergency department (ED) and hospital discharge implemented within 2 urban academic medical centers. Summary: Expanding access to medications for opioid...
5.
Feder K, Patel E, Buresh M, Kirk G, Mehta S, Genberg B
Drug Alcohol Depend
. 2023 Sep;
251:110954.
PMID: 37716287
Background: Overdose deaths increased during the COVID-19 pandemic in the United States. Less is known about drug use behavior changes during the same time period. We examined differences in non-fatal...
6.
Calcaterra S, Buresh M, Weimer M
J Hosp Med
. 2023 Apr;
18(12):1134-1138.
PMID: 37016586
No abstract available.
7.
Racha S, Buresh M, Fingerhood M
Psychiatr Clin North Am
. 2022 Sep;
45(3):335-346.
PMID: 36055727
The incidence of opioid use disorder (OUD) and overdose deaths is rising yearly within the United States. Many cases are associated with illicitly manufactured fentanyl use. In addition to offering...
8.
Calcaterra S, Bottner R, Martin M, Englander H, Weinstein Z, Weimer M, et al.
J Hosp Med
. 2022 Jul;
17(9):679-692.
PMID: 35880821
Background: Hospitalizations related to the consequences of opioid use are rising. National guidelines directing in-hospital opioid use disorder (OUD) management do not exist. OUD treatment guidelines intended for other treatment...
9.
Buresh M, Nahvi S, Steiger S, Weinstein Z
J Subst Abuse Treat
. 2022 Jul;
141:108832.
PMID: 35870437
Since 2013, fentanyl and fentanyl analogs, which are significantly more potent than heroin, have been increasingly prevalent in the opioid drug supply. A need exists to adapt methadone dosing from...
10.
Genberg B, Gicquelais R, Astemborski J, Knight J, Buresh M, Sun J, et al.
Drug Alcohol Depend
. 2021 Nov;
229(Pt B):109152.
PMID: 34749056
Objective: The objective of this study was to examine trends in fatal and nonfatal overdose in a community-based sample of current and former people who inject drugs (PWID). Methods: Data...